FEDERAL · 42 U.S.C. · Chapter SUBCHAPTER XXXI—WORLD TRADE CENTER HEALTH PROGRAM

§300mm–33. Followup monitoring and treatment of other individuals with WTC-related health conditions

42 U.S.C. § §300mm–33. Followup monitoring and treat
Title42The Public Health and Welfare
ChapterSUBCHAPTER XXXI—WORLD TRADE CENTER HEALTH PROGRAM
Partsubpart 2—wtc survivors

This text of 42 U.S.C. § §300mm–33. Followup monitoring and treat (§300mm–33. Followup monitoring and treatment of other individuals with WTC-related health conditions) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
42 U.S.C. § §300mm–33. Followup monitoring and treat.

Text

(a)In general Subject to subsection (c), the provisions of section 300mm–32 of this title shall apply to the followup monitoring and treatment of WTC-related health conditions in the case of individuals described in subsection (b) in the same manner as such provisions apply to the followup monitoring and treatment of WTC-related health conditions for certified-eligible WTC survivors.
(b)Individuals described An individual described in this subsection is an individual who, regardless of location of residence—
(1)is not an enrolled WTC responder or a certified-eligible WTC survivor; and
(2)is diagnosed at a Clinical Center of Excellence with a WTC-related health condition for certified-eligible WTC survivors.
(c)Limitation The WTC Program Administrator shall limit benefits for any fisca

Free access — add to your briefcase to read the full text and ask questions with AI

Related

§ 300m
42 U.S.C. § 300m

Source Credit

History

(July 1, 1944, ch. 373, title XXXIII, §3323, as added Pub. L. 111–347, title I, §101, Jan. 2, 2011, 124 Stat. 3652.)

Cite This Page — Counsel Stack

Bluebook (online)
42 U.S.C. § §300mm–33. Followup monitoring and treat, Counsel Stack Legal Research, https://law.counselstack.com/usc/42/§300mm–33. Followup monitoring and treat.